Hester Biosciences Stock Screener | Share Price & Fundamental Analysis
HESTERBIO
Pharmaceuticals
Screen Hester Biosciences share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price NSE
₹1592.60
▼
-11.60 (-0.72%)
Share Price BSE
₹1573.70
▼
-32.05 (-2.00%)
Market Cap
₹1,344.00 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
3.98
EPS (TTM)
₹33.89
Dividend Yield
0.44%
Debt to Equity
0.76
52W High
₹2381.50
52W Low
₹1254.50
Operating Margin
23.00%
Profit Margin
2.63%
Revenue (TTM)
₹76.00
EBITDA
₹14.00
Net Income
₹2.00
Total Assets
₹653.00
Total Equity
₹327.00
Hester Biosciences Share Price History - Stock Screener Chart
Screen HESTERBIO historical share price movements with interactive charts. Analyze price trends and patterns.
Hester Biosciences Company Profile - Fundamental Screener
Screen Hester Biosciences company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for HESTERBIO shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE782E01017
Hester Biosciences Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen HESTERBIO balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 653 | 662 | 670 | 562 | 411 | 387 | 300 | 244 | 213 | 186 |
| Current Assets | 195 | 215 | 228 | 195 | 162 | 159 | 143 | 98 | 80 | 74 |
| Fixed Assets | 233 | 240 | 259 | 237 | 133 | 142 | 145 | 110 | 103 | 65 |
| Liabilities | ||||||||||
| Total Liabilities | 653 | 662 | 670 | 562 | 411 | 387 | 300 | 244 | 213 | 186 |
| Current Liabilities | 202 | 254 | 233 | 198 | 114 | 97 | 70 | 44 | 48 | 41 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 327 | 303 | 289 | 267 | 236 | 207 | 181 | 145 | 127 | 106 |
| Share Capital | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 |
| Reserves & Surplus | 306 | 283 | 271 | 252 | 220 | 193 | 169 | 132 | 113 | 93 |
Screen HESTERBIO income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun | 2022-Sept | 2022-Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 76 | 88 | 83 | 84 | 84 | 87 | 72 | 71 | 90 | 76 | 69 | 64 | 55 | 78 | 81 |
| Expenses | 63 | 61 | 59 | 63 | 65 | 65 | 58 | 56 | 74 | 57 | 57 | 46 | 43 | 60 | 56 |
| EBITDA | 14 | 26 | 24 | 21 | 20 | 22 | 14 | 15 | 17 | 19 | 12 | 18 | 12 | 18 | 25 |
| Operating Profit % | 23.00% | 27.00% | 17.00% | 20.00% | 21.00% | 23.00% | 8.00% | 17.00% | 16.00% | 19.00% | 15.00% | 18.00% | 15.00% | 17.00% | 25.00% |
| Depreciation | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 5 | 5 | 4 | 4 | 5 | 5 | 5 | 5 |
| Interest | 6 | 2 | 2 | 7 | 5 | 6 | -4 | 1 | 3 | 8 | 2 | 2 | 2 | 3 | 4 |
| Profit Before Tax | 4 | 20 | 17 | 10 | 11 | 12 | 13 | 8 | 9 | 7 | 6 | 11 | 6 | 10 | 16 |
| Tax | 2 | 3 | 3 | 4 | 3 | 4 | 2 | 3 | 2 | 3 | 2 | 2 | 2 | 4 | 4 |
| Net Profit | 2 | 17 | 14 | 6 | 8 | 8 | 11 | 6 | 7 | 4 | 4 | 9 | 4 | 7 | 12 |
| EPS | 1.82 | 20.33 | 16.85 | 7.52 | 8.80 | 9.86 | 13.41 | 6.72 | 7.89 | 4.75 | 4.73 | 10.59 | 4.19 | 7.77 | 14.29 |
Hester Biosciences Cash Flow Screener - Liquidity Fundamentals
Screen HESTERBIO cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 65 | 48 | 24 | 9 | 58 | 37 | 47 | 38 | 35 | 19 |
| Investing Activities | -20 | -23 | -77 | -117 | -42 | -73 | -21 | -26 | -30 | -13 |
| Financing Activities | -52 | -26 | 42 | 112 | -18 | 19 | 3 | -11 | 2 | -7 |
| Net Cash Flow | -7 | 0 | -12 | 4 | -2 | -17 | 28 | 1 | 6 | -1 |
Screen HESTERBIO shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 53.73% | 53.73% | 53.73% | 53.73% | 53.73% | 53.73% | 53.73% | 53.73% |
| FII Holding | 0.87% | 0.52% | 0.53% | 0.43% | 0.52% | 0.61% | 0.59% | 0.00% |
| DII Holding | 0.02% | 0.02% | 0.00% | 0.00% | 0.00% | 0.02% | 0.02% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 32.64% | 32.80% | 32.92% | 33.32% | 32.63% | 32.67% | 32.68% | 33.03% |
| Other Holding | 12.73% | 12.93% | 12.82% | 12.52% | 13.12% | 12.97% | 12.97% | 13.24% |
| Shareholder Count | 11,853 | 11,810 | 12,260 | 12,844 | 11,305 | 11,538 | 11,473 | 13,120 |
Hester Biosciences Dividend Screener - Share Yield Analysis
Screen HESTERBIO dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2025-March | ₹7.00 | 0.44% |
| 2024-March | ₹6.00 | 0.48% |
| 2023-March | ₹8.00 | 0.57% |
| 2022-March | ₹10.00 | 0.64% |
| 2021-March | ₹10.00 | 0.37% |
| 2020-March | ₹6.60 | 0.34% |
| 2019-March | ₹11.00 | 1.20% |
| 2018-March | ₹10.00 | 0.65% |
| 2017-March | ₹5.30 | 0.33% |
| 2016-March | ₹0.00 | 0.00% |
Hester Biosciences Index Membership - Market Screener Classification
Screen HESTERBIO by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Hester Biosciences Market Events Screener - Corporate Actions
Screen HESTERBIO market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Dividend | ₹ 8.00 /share | -5.18% | ||
| 2025-11-12 | 2025-11-12 | Quarterly Result Announcement | NA | 0.69% |
| 2025-08-13 | 2025-08-13 | Annual General Meeting | NA | 7.94% |
| 2025-08-06 | 2025-08-06 | Dividend | ₹ 7.00 /share | 19.29% |
| 2025-08-01 | 2025-08-01 | Quarterly Result Announcement | NA | 3.70% |
| 2025-05-09 | 2025-05-09 | Quarterly Result Announcement | NA | -4.77% |
| 2025-01-30 | 2025-01-30 | Quarterly Result Announcement | NA | -4.79% |
| 2024-10-28 | 2024-10-28 | Quarterly Result Announcement | NA | -8.20% |
| 2024-08-29 | 2024-08-29 | Annual General Meeting | NA | -22.24% |
| 2024-08-22 | 2024-08-23 | Dividend | ₹ 6.00 /share | 52.21% |
| 2022-08-11 | 2022-08-12 | Dividend | ₹ 10.00 /share | -1.86% |
| 2021-08-05 | 2021-08-07 | Dividend | ₹ 10.00 /share | -14.97% |
Hester Biosciences Competitors Screener - Peer Comparison
Screen HESTERBIO competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 412,734 | 39.30 | 54,729 | 9.71% | 10,980 | 39.06 |
| Divis Laboratories | 168,851 | 68.25 | 9,712 | 18.67% | 2,191 | 44.96 |
| Torrent Pharmaceuticals | 129,357 | 59.98 | 11,539 | 6.99% | 1,911 | 59.35 |
| Cipla | 120,557 | 22.21 | 28,410 | 7.12% | 5,291 | 42.76 |
| Dr Reddys Laboratories | 105,645 | 18.46 | 33,741 | 16.73% | 5,725 | 49.97 |
| Lupin | 95,023 | 21.85 | 22,910 | 13.74% | 3,306 | 50.10 |
| Zydus Life Science | 90,707 | 18.09 | 23,511 | 18.55% | 4,615 | 34.06 |
| Mankind Pharma | 88,846 | 50.78 | 12,744 | 20.90% | 2,007 | 40.67 |
| Aurobindo Pharma | 68,901 | 20.36 | 32,346 | 9.43% | 3,484 | 46.33 |
| Alkem Laboratories | 65,390 | 27.28 | 13,458 | 3.70% | 2,216 | 37.45 |
Hester Biosciences Company Announcements - News Screener
Screen HESTERBIO latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-01-06 | Closure of Trading Window | View |
| 2025-11-20 | Intimation Under Regulation 30(5) Of The SEBI (LODR) Regulations 2015 | View |
| 2025-11-20 | Announcement under Regulation 30 (LODR)-Change in Management | View |
| 2025-11-20 | Outcome Of Resolutions Passed By The Board Of Directors By Circulation | View |
| 2025-11-14 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | View |
| 2025-11-13 | Resignation Of Chief Financial Officer (CFO) | View |
| 2025-11-13 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-12 | Intimation Regarding Speech Of Executive Director At Q2 & H1 FY2025-26 Earnings Conference Call | View |
| 2025-11-12 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | View |
| 2025-11-12 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2025-11-12 | Financial Results For The Period Ended 30 September 2025 | View |
| 2025-11-12 | Board Meeting Outcome for Outcome Of Board Meeting Held On 12 November 2025 | View |
| 2025-11-05 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-11-04 | Board Meeting Intimation for Financial Results | View |
| 2025-10-08 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-09-29 | Closure of Trading Window | View |
| 2025-09-05 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | View |
| 2025-09-05 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | View |
| 2025-08-13 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |
| 2025-08-13 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |